Loading clinical trials...
Loading clinical trials...
Chidamide, Decitabine Combined With Priming IAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Conditions
Interventions
CDIAG regimen
Locations
1
China
The First Affliated Hospital of Soochow University
Suzhou, Jiangsu, China
Start Date
January 1, 2018
Primary Completion Date
December 31, 2020
Completion Date
March 16, 2021
Last Updated
March 17, 2022
NCT04050280
NCT03063203
Lead Sponsor
The First Affiliated Hospital of Soochow University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions